Arcturus Therapeutics board fires CEO

drugs, medicine  picture: thinkstock
drugs, medicine picture: thinkstock

Israeli company Alcobra merged with US-based Arcturus and the combined company still has Israeli investors.

Israeli biotech company Alcobra, which was floated on Nasdaq in 2013 but after failure in development of its product for treatment of attention deficit hyperactivity disorder was merged with US company Arcturus Therapeutics, is still not finding life easy, even in its new guise.

Arcturus announced on Friday that it had dismissed its president and CEO, Joseph Payne, who was the founder and CEO of Arcturus as a private company, and continued as CEO after the merger with Alcobra. Mark R. Herbert, vice president of Business Development and Alliance Management, has been appointed to serve as interim president. The announcement does not attempt to hide the fact that Payne was dismissed by the board of directors and did not leave of his own accord. Following the announcement, the company's share price fell 18%, and it now has a market cap of some $62 million. At the time of the merger with Alcobra, it had $35 million cash, which came from the Israeli company.

Arcturus is a drug development company. Its current troubles are an internal matter in the US company that was merged with Alcobra, but it is interesting from an IsraeIi point of view, because Israelis are still among its investors. Alcobra shareholders received 40% of the merged company. The largest Israeli shareholder at the time of the merger was activist fund Brosh Capital, which held 6.6% of Arcturus after the merger.

Brosh Capital is no longer a party at interest in Arcturus. It apparently started to sell shares immediately after the merger. In the month following the merger announcement, in September 2017, the share price rose 54%, but it has lost half its value since that peak.

The decline was apparently caused by sales of shares by investors in Alcobra who were not interested in the merged company, among them Brosh Capital, which appears to have sold its holdings at a profit of 30-40%.

Published by Globes [online], Israel business news - www.globes-online.com - on February 5, 2018

© Copyright of Globes Publisher Itonut (1983) Ltd. 2018

drugs, medicine  picture: thinkstock
drugs, medicine picture: thinkstock
Bank Leumi branch credit: Eyal Izhar Leumi posts largest ever bank profit

Bank Leumi earned a profit of NIS 9.8 billion in 2024, 40% more than in 2023.

Medical research  credit: Shutterstock Boston Scientific buys Israeli medical device co SoniVie

The US medical device company will pay up to $540 million for the Rehovot-based intravascular ultrasound device developer for treating high blood pressure.

Dina Ben Tal Ganancia  credit: Guy Kushi & Yariv Fein El Al agrees to shoulder higher security costs

In exchange for lowering the government's security spending burden, El Al expects state permission to distribute dividends.

Playtika head office in Herzliya Credit: Eyal Izhar Playtika stock sinks to all-time low

The Israeli mobile games developer's share price has fallen over 80% since its Wall Street IPO four years ago.

Ronit Harel Ben Zeev credit: Osnat Rom S&P Maalot Israel CEO: Capital market needs more women

Ronit Harel Ben Zeev talks to "Globes" about she came to work at the Tel Aviv Stock Exchange, the Israeli economy and S&P Maalot.

Building work on Sarona Hotel credit: Shutterstock Work moves slowly ahead on one of Israel's biggest hotels

After years of delays, construction work resumed several months ago on the 800-room, 47-floor Sarona Hotel in Tel Aviv.

New car deliveries in Israel credit: Shutterstock New car deliveries in Israel hit five year low

Deliveries of gasoline, hybrid and plug-in vehicles were led by Hyundai with 9,251 deliveries since the beginning of the year.

Yadin Antebi  credit: Jonathan Bloom Hapoalim posts record annual profit, sets targets

Bank Hapoalim expects to post a profit of NIS 8.5-9.5 billion in each of the years 2025 and 2026, but expresses concern about the real estate sector.

Venture capital credit: Shutterstock Andreessen Horowitz boosting Israel VC investments

According to the IVC-Gornitzky-KPMG-Israel Innovation Authority investors report for 2024, the US venture capital fund has become one of the most active foreign investors in Israel.

Wiz Sarona offices inset Assaf Rappaport credit: Wiz Omer Hacohen Wiz leases five floors in renovated Sarona building

Exclusive: The Israeli cloud security company is leasing 5,500 square meters of space in a preserved Tel Aviv Templar building.

Tel Aviv Midtown - inset Ilya Sutskever credit: Shutterstock SSI Israel hires first senior researchers

Exclusive: "Globes" names some of the senior researchers hired in Tel Aviv by Ilya Sutskever's Safe Super Intelligence.

Raising dollars credit: Shutterstock Israeli startups raised over $550m in February

Israeli startups have raised $1.25 billion in the first two months of 2025, up from $800 million in the corresponding period of 2024.

Ashdod's South Port  credit: Wikipedia New regulation for Israel's ports underway

The reform, though not perfect and still liable to met with opposition, is vital to efficient handling of Israel's trade.

BIG Glilot opening weekend credit: BIG 150,000 jam into BIG Glilot over first weekend

Israel's newly opened and biggest shopping center recorded huge sales on Friday and Saturday, despite traffic congestion at the car park entrance.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Jerusalem, Ma'aleh Adumim, Hod Hasharon, Zikron Yaakov, Kiryat Bialik, and Beersheva.

Nochi Dankner  credit: Tamar Matsafi Court orders seizure of Nochi Dankner assets worth NIS 50m

The order follows the cancelation of the settlement of the class action brought by IDB shareholders against Dankner and his partner Itay Strum..

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018